Literature DB >> 10708368

A new single-copy mycobacterial plasmid, pMF1, from Mycobacterium fortuitum which is compatible with the pAL5000 replicon.

G Bachrach1, M J Colston, H Bercovier, D Bar-Nir, C Anderson, K G Papavinasasundaram.   

Abstract

A 9.2 kb cryptic Mycobacterium fortuitum plasmid, pMF1, was isolated from strain 110 and its restriction map constructed. A 4.2 kb HindIII fragment of pMF1 was found to support replication in mycobacteria and this fragment was cloned and sequenced to characterize the replication elements of the plasmid. Computer analysis identified a putative Rep protein (362 amino acids) with high homology to the putative Rep protein of the Mycobacterium celatum plasmid pCLP and limited homology, mostly in the N-terminal region, to the Rep proteins of Mycobacterium avium pLR7, M. fortuitum pJAZ38 and Mycobacterium scrofulaceum pMSC262. A region containing a putative ori site was located upstream of the rep gene; this region displayed high homology at the nucleotide level with the predicted ori of pCLP and pJAZ38. A plasmid carrying the 4.2 kb HindIII fragment and a kanamycin resistance marker, designated pBP4, was maintained as a single-copy plasmid in Mycobacterium smegmatis and was stably inherited in the absence of antibiotic selection. Plasmid pBP4 was incompatible with the pJAZ38 replicon but was compatible with the widely used pAL5000 replicon, indicating that among the mycobacterial vectors now available there are two incompatibility groups. Significantly, the plasmid was able to replicate in the pathogen Mycobacterium tuberculosis, making it a useful tool for gene expression studies. To provide a choice of restriction sites and easy manipulation, a 2.1 kb fragment containing the minimal replication region was cloned to make the mycobacterial shuttle vector pBP10, which showed similar stability to pBP4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708368     DOI: 10.1099/00221287-146-2-297

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  17 in total

Review 1.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Electroporation of Mycobacteria.

Authors:  Tanya Parish
Journal:  Methods Mol Biol       Date:  2021

3.  Mapping essential domains of Mycobacterium smegmatis WhmD: insights into WhiB structure and function.

Authors:  Tirumalai R Raghunand; William R Bishai
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

4.  Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein domains target LipY lipases of pathogenic mycobacteria to the cell surface via the ESX-5 pathway.

Authors:  Maria H Daleke; Alessandro Cascioferro; Karin de Punder; Roy Ummels; Abdallah M Abdallah; Nicole van der Wel; Peter J Peters; Joen Luirink; Riccardo Manganelli; Wilbert Bitter
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

5.  Functional characterization of a catabolic plasmid from polychlorinated- biphenyl-degrading Rhodococcus sp. strain RHA1.

Authors:  René Warren; William W L Hsiao; Hisashi Kudo; Matt Myhre; Manisha Dosanjh; Anca Petrescu; Hiroyuki Kobayashi; Satoru Shimizu; Keisuke Miyauchi; Eiji Masai; George Yang; Jeff M Stott; Jacquie E Schein; Heesun Shin; Jaswinder Khattra; Duane Smailus; Yaron S Butterfield; Asim Siddiqui; Robert Holt; Marco A Marra; Steven J M Jones; William W Mohn; Fiona S L Brinkman; Masao Fukuda; Julian Davies; Lindsay D Eltis
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

6.  A replication clock for Mycobacterium tuberculosis.

Authors:  Wendy P Gill; Nada S Harik; Molly R Whiddon; Reiling P Liao; John E Mittler; David R Sherman
Journal:  Nat Med       Date:  2009-02-01       Impact factor: 53.440

7.  The metabolic activity of Mycobacterium tuberculosis, assessed by use of a novel inducible GFP expression system, correlates with its capacity to inhibit phagosomal maturation and acidification in human macrophages.

Authors:  Bai-Yu Lee; Daniel L Clemens; Marcus A Horwitz
Journal:  Mol Microbiol       Date:  2008-03-19       Impact factor: 3.501

8.  Mycobacterium tuberculosis strains lacking surface lipid phthiocerol dimycocerosate are susceptible to killing by an early innate host response.

Authors:  Tracey A Day; John E Mittler; Molly R Nixon; Cullen Thompson; Maurine D Miner; Mark J Hickey; Reiling P Liao; Jennifer M Pang; Dmitry M Shayakhmetov; David R Sherman
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

9.  A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis.

Authors:  Marcus A Horwitz; Günter Harth
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Metabolic regulation of mycobacterial growth and antibiotic sensitivity.

Authors:  Seung-Hun Baek; Alice H Li; Christopher M Sassetti
Journal:  PLoS Biol       Date:  2011-05-24       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.